Gravitate Health will deliver an open source digital platform supporting G-Lens functionally, demonstrated in a number of testing scenarios, and a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like electronic production information (ePI) as a tool for Risk Minimization.
Gravitate Health services and G-lens will be developed and tested within the project, using an evaluation framework to test the efficiency, efficacy, and safety of Gravitate-Health services.
Gravitate Health’s main objectives are:
1 – to develop an integrated, digital, user-centric health information solution with two-way communication for the public, so that health information from a set of trusted sources is available and understandable, such as the package leaflet content and EHR-IPS (International Patient Summary).
2 – to promote adherence to treatment, safer use of medication (Pharmacovigilance), better health outcomes and quality of life through improved availability and understanding of health information.
In Gravitate-Health, Global Health Connector engaged four ecosystems – two in Europe and two beyond – to contribute to the cost-benefit analysis of the G-Lens solution, strengthening the project’s evidence base and real-world relevance. We also contributed to the project’s hackathon in Athens, supporting innovation uptake and cross-sector collaboration.
Beyond individual projects, our team was present at key international events throughout 2025, promoting research and innovation results through dedicated sessions and panels, and amplifying impact through our network of 80+ international ecosystems and a broad community of members.
The Gravitate Health is a public – private partnership with 40 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI Associated Partners.
The full list of partners is available here.
